Carrie L. Bourdow - Net Worth and Insider Trading
Carrie L. Bourdow Net Worth
The estimated net worth of Carrie L. Bourdow is at least $20,824 dollars as of 2024-06-15. Carrie L. Bourdow is the President & CEO of Trevena Inc and owns about 52,060 shares of Trevena Inc (TRVN) stock worth over $20,824. Carrie L. Bourdow is also the Director of Nabriva Therapeutics PLC and owns about 397 shares of Nabriva Therapeutics PLC (NBRVF) stock worth over $0. Details can be seen in Carrie L. Bourdow's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Carrie L. Bourdow has not made any transactions after 2022-08-01 and currently still holds the listed stock(s).
Transaction Summary of Carrie L. Bourdow
Carrie L. Bourdow Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carrie L. Bourdow owns 4 companies in total, including Nabriva Therapeutics PLC (NBRVF) , Sesen Bio Inc (SESN) , and Trevena Inc (TRVN) among others .
Click here to see the complete history of Carrie L. Bourdow’s form 4 insider trades.
Insider Ownership Summary of Carrie L. Bourdow
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NBRVF | Nabriva Therapeutics PLC | 2022-08-01 | Director |
| SESN | Sesen Bio Inc | 2020-02-24 | director |
| TRVN | Trevena Inc | 2022-12-02 | director & President & CEO |
 | | 2020-02-24 | director |
Carrie L. Bourdow Latest Holdings Summary
Carrie L. Bourdow currently owns a total of 2 stocks. Among these stocks, Carrie L. Bourdow owns 52,060 shares of Trevena Inc (TRVN) as of June 28, 2021, with a value of $20,824 and a weighting of 100%. Carrie L. Bourdow also owns 397 shares of Nabriva Therapeutics PLC (NBRVF) as of August 1, 2022, with a value of $0 and a weighting of 0%.
Latest Holdings of Carrie L. Bourdow
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TRVN | Trevena Inc | 2021-06-28 | 52,060 | 0.40 | 20,824 |
| NBRVF | Nabriva Therapeutics PLC | 2022-08-01 | 397 | 0.00 | 0 |
Holding Weightings of Carrie L. Bourdow
Carrie L. Bourdow Form 4 Trading Tracker
According to the SEC Form 4 filings, Carrie L. Bourdow has made a total of 1 transactions in Trevena Inc (TRVN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Trevena Inc is the acquisition of 2,248 shares on June 28, 2021, which cost Carrie L. Bourdow around $100,598.
According to the SEC Form 4 filings, Carrie L. Bourdow has made a total of 2 transactions in Nabriva Therapeutics PLC (NBRVF) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Nabriva Therapeutics PLC is the sale of 342 shares on August 1, 2022, which brought Carrie L. Bourdow around $1,452.
Insider Trading History of Carrie L. Bourdow
- 1
Carrie L. Bourdow Trading Performance
GuruFocus tracks the stock performance after each of Carrie L. Bourdow's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Carrie L. Bourdow is 21.06%. GuruFocus also compares Carrie L. Bourdow's trading performance to market benchmark return within the same time period. The performance of stocks bought by Carrie L. Bourdow within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Carrie L. Bourdow's insider trading performs compared to the benchmark.
Performance of Carrie L. Bourdow
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4 | | | | | |
| Relative Return to S&P 500(%) | 0.49 | | | | | |
Carrie L. Bourdow Ownership Network
Carrie L. Bourdow Owned Company Details
What does Nabriva Therapeutics PLC do?
Who are the key executives at Nabriva Therapeutics PLC?
Carrie L. Bourdow is the Director of Nabriva Therapeutics PLC. Other key executives at Nabriva Therapeutics PLC include Chief Executive Officer Hogan H Michael Iii , Chief Financial Officer David Maggio , and Chief Executive Officer Broom Colin Md .
Nabriva Therapeutics PLC (NBRVF) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Nabriva Therapeutics PLC (NBRVF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nabriva Therapeutics PLC (NBRVF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Nabriva Therapeutics PLC (NBRVF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nabriva Therapeutics PLC Insider Transactions
Carrie L. Bourdow Mailing Address
Above is the net worth, insider trading, and ownership report for Carrie L. Bourdow. You might contact Carrie L. Bourdow via mailing address: C/o Trevena, Inc., 1018 West 8th Avenue, Suite A, King Of Prussia Pa 19406.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
